UP plans US FDA-accredited medical device testing lab
Lucknow: In a major push to strengthen India’s medical device and pharmaceutical manufacturing ecosystem, the Uttar Pradesh govt is working on an ambitious project to establish a US FDA-accredited medical…
Union Minister Anupriya Patel launches NBEMS online AI training programme for doctors
New Delhi: Union Minister of State for Health and Family Welfare, Smt. Anupriya Patel, today launched an online training programme on Artificial Intelligence (AI) in Medical Education developed by the…
English alphabets can’t be trademarked: Delhi HC
New Delhi: The Delhi High Court recently held that English alphabets cannot be monopolised through trademark law and refused interim protection to the mark ‘A TO Z’ used by a pharmaceutical…
IIT Roorkee develops next-generation antibody discovery platform
Dehradun: In a significant step towards affordable healthcare, pandemic preparedness, and indigenous biotechnology innovation, the Indian Institute of Technology Roorkee (IIT Roorkee) has developed a next-generation antibody discovery platform with…
CDSCO to dispose online applications pending for more than two years
New Delhi: In an effort to reduce the backlog and clear the long-pending applications with lack of response from the applicants, the Central Drugs Standard Control Organisation (CDSCO) has introduced…
DoP may exempt 11 more drugs from public procurement rules
New Delhi: The Department of Pharmaceuticals (DoP) has proposed to add 11 more drugs including insulin and monoclonal antibodies to the list of 84 drug formulations it has mentioned in…
Centre plans separate licence regime for bulk drugs, APIs: Report
India is preparing to revamp its pharmaceutical licensing system amid growing scrutiny over drug safety lapses. Mint has learnt that the government is working on a separate wholesale licensing framework…
DoP includes member of HTAIn in expert committee on pricing of drugs
New Delhi: Department of Pharmaceuticals (DoP) has added an expert representative from the Health Technology Assessment of India (HTAIn) under the Department of Health Research (DHR) as a member of…
Bulk drug imports from China slow
There is still some way until India’s dependence on imports of active pharmaceutical ingredients (APIs) and intermediates from China reduces, but the growth rate of imports has come down. While…















